Annovis Bio, Inc. (ANVS)
NYSE: ANVS · Real-Time Price · USD
6.54
-0.14 (-2.10%)
Nov 20, 2024, 4:00 PM EST - Market closed
Annovis Bio Market Cap
Annovis Bio has a market cap or net worth of $85.37 million as of November 21, 2024. Its market cap has increased by 32.26% in one year.
Market Cap
85.37M
Enterprise Value
72.74M
1-Year Change
32.26%
Ranking
Category
Stock Price
$6.54
Market Cap Chart
Since January 29, 2020, Annovis Bio's market cap has increased from $62.51M to $85.37M, an increase of 36.58%. That is a compound annual growth rate of 6.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2024 | 87.20M | -54.56% |
| Dec 29, 2023 | 191.90M | 75.03% |
| Dec 30, 2022 | 109.64M | -23.01% |
| Dec 31, 2021 | 142.41M | 174.06% |
| Dec 31, 2020 | 51.96M | -16.87% |
| Jan 29, 2020 | 62.51M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Invivyd | 89.71M |
| WORK Medical Technology Group LTD | 89.45M |
| Veru Inc. | 88.90M |
| HilleVax | 88.03M |
| Allakos | 87.94M |
| SELLAS Life Sciences Group | 87.17M |
| Genelux | 85.94M |
| Adicet Bio | 85.70M |